Cardiomyopathy Trial, Recruiting NCT01076660 Sponsor: Johns Hopkins University Condition: Cardiomyopathy
Back to Cardiomyopathy

Cardiomyopathy Trial, Recruiting

NCT01076660
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People whose heart is pumping at 35% or less of its normal capacity, and who have been referred by their doctor to have a defibrillator device (ICD) implanted to prevent a serious heart rhythm problem from happening in the future (not because one has already occurred)
  • People between the ages of 21 and 80 years old
  • People whose treating doctor has given permission for them to take part

Who may not be able to join:

  • People who are unwilling or unable to give their consent to participate
  • People who cannot have an MRI scan due to metal objects in their body, such as a previously implanted heart pacemaker, surgical clips in the brain, or metal fragments lodged in the body
  • People under 18 years of age
  • People who are pregnant
  • People with the most severe stage of heart failure (known as NYHA Class IV), which means the heart is severely limiting everyday activity
  • People with long-term kidney disease where the kidneys are not filtering at a sufficient level, or any level of sudden kidney problems (confirm with trial site for specific details)
  • People who experience severe anxiety or distress in enclosed spaces (claustrophobia)
  • People who have previously had a bad reaction to a type of MRI dye called gadolinium-based contrast

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Katherine Wu, MD, Johns Hopkins University

Phone: 410-502-7283

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 October 2003
Est. completion
1 June 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Composite SCD outcomes

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov